Koers Omni Bio Pharmaceutical Inc OTC Bulletin Board
Aandelen
Biotechnologie & Medisch Onderzoek
Omzet 2013 | - | Omzet 2014 | - | Marktkapitalisatie | 10,89 mln. 10,02 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2013 | -7 mln. -6,44 mln. | Nettowinst (verlies) 2014 | -2 mln. -1,84 mln. | EV/omzet 2013 | - |
Nettoschuld 2013 | 441K 406K | Nettoschuld 2014 | 752K 692K | EV/omzet 2014 | - |
K/w-verhouding 2013 |
-1,5
x | K/w-verhouding 2014 |
-4,18
x | Werknemers | - |
Dividendrendement 2013 * |
-
| Dividendrendement 2014 |
-
| Vrij verhandelbaar | 100% |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+9,42% | 114 mld. | |
+11,84% | 104 mld. | |
-14,15% | 22,41 mld. | |
-1,05% | 22,28 mld. | |
-5,29% | 19,07 mld. | |
-38,29% | 18 mld. | |
-4,16% | 17,89 mld. | |
+7,99% | 14,28 mld. | |
+36,24% | 12,55 mld. |